{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:25:17Z","timestamp":1794925517064,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"AstraZeneca"},{"name":"Glaxo-Smith & Kline"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006259","name":"Teva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.waojou.2018.12.001","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T20:20:35Z","timestamp":1549398035000},"page":"100007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Shadow cost of oral corticosteroids-related adverse events: A\u00a0pharmacoeconomic evaluation applied to real-life data from\u00a0the\u00a0Severe\u00a0Asthma Network in Italy (SANI) registry"],"prefix":"10.1016","volume":"12","author":[{"given":"Giorgio Walter","family":"Canonica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Lorenzo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Matteo","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Di Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Bucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Crimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Paggiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolamo","family":"Pelaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Passalaqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianenrico","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Heffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Barbuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Camiciottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Caminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselda","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Costantino Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Crimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangiola","family":"Crivellaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"D'Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Foschino Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Guarnieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Menzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Patella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Puggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminia","family":"Ridolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Savi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Scichilone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Solidoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.waojou.2018.12.001_bib2","first-page":"S7","article-title":"Epidemiology and economic burden of asthma","volume":"5","author":"Loftus","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.waojou.2018.12.001_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1183\/09031936.00061611","article-title":"Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010","volume":"39","author":"de Marco","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2018.12.001_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.11606\/S1518-8787.2018052000153","article-title":"Estimated cost of asthma in outpatient treatment: a real-world study","volume":"52","author":"Costa","year":"2018","journal-title":"Rev Saude Publica"},{"issue":"6S2","key":"10.1016\/j.waojou.2018.12.001_bib5","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.amepre.2017.07.019","article-title":"Prevalence and medical costs of chronic diseases among adult medicaid beneficiaries","volume":"53","author":"Chapel","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.waojou.2018.12.001_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40248-016-0080-1","article-title":"Cost of persistent asthma in Italy","volume":"11","author":"Dal Negro","year":"2016","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"10.1016\/j.waojou.2018.12.001_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000338998","article-title":"The cost of persistent asthma in Europe: an international population-based study in adults","volume":"160","author":"Accordini","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2018.12.001_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1513\/AnnalsATS.201703-259OC","article-title":"The economic burden of asthma in the United States, 2008-2013","volume":"15","author":"Nurmagambetov","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.waojou.2018.12.001_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12325-015-0204-6","article-title":"Patient reported burden of asthma on resource use and productivity across 11 countries in Europe","volume":"32","author":"Fletcher","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.waojou.2018.12.001_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.rmed.2018.03.018","article-title":"The projected economic and health burden of sub-optimal asthma control in Canada","volume":"138","author":"Zafari","year":"2018","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.waojou.2018.12.001_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12931-016-0374-z","article-title":"Determinants and impact of suboptimal asthma control in Europe: the International Cross-Sectional and Longitudinal Assessment on Asthma Control (LIAISON) study","volume":"17","author":"Braido","year":"2016","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.waojou.2018.12.001_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2500\/aap.2015.36.3908","article-title":"Severe asthma: epidemiology, burden of illness, and heterogeneity","volume":"36","author":"Lang","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.waojou.2018.12.001_bib13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2018.12.001_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12931-018-0719-x","article-title":"Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)","volume":"19","author":"Larsson","year":"2018","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.waojou.2018.12.001_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaip.2014.05.005","article-title":"The prevalence of severe asthma and low asthma control among Danish adults","volume":"2","author":"von B\u00fclow","year":"2014","journal-title":"Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2018.12.001_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.waojou.2018.12.001_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1183\/09031936.04.00004904","article-title":"Asthma severity and medical resource utilisation","volume":"23","author":"Antonicelli","year":"2004","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.waojou.2018.12.001_bib18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaip.2016.12.023","article-title":"Burden of chronic oral corticosteroid use by adults with persistent asthma","volume":"5","author":"Zeiger","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2018.12.001_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thoraxjnl-2015-207630","article-title":"Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry","volume":"71","author":"Sweeney","year":"2016","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.waojou.2018.12.001_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/03007995.2016.1233101","article-title":"Burden of systemic glucocorticoid-related complications in severe asthma","volume":"33","author":"Lefebvre","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.waojou.2018.12.001_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.otc.2010.04.003","article-title":"A\u00a0comprehensive review of the adverse effects of systemic corticosteroids","volume":"43","author":"Poetker","year":"2010","journal-title":"Otolaryngol Clin"},{"issue":"11","key":"10.1016\/j.waojou.2018.12.001_bib22","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","article-title":"Long-term systemic corticosteroid exposure: a systematic literature review","volume":"39","author":"Rice","year":"2017","journal-title":"Clin Therapeut"},{"issue":"3","key":"10.1016\/j.waojou.2018.12.001_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaip.2018.01.025","article-title":"Inhaled corticosteroids safety and adverse\u00a0effects in patients with asthma","volume":"6","author":"Heffler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2018.12.001_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/rheumatology\/keh594","article-title":"The cost of glucocorticoid-associated adverse events in rheumatoid arthritis","volume":"44","author":"Pisu","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.waojou.2018.12.001_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","article-title":"The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use","volume":"103","author":"Manson","year":"2009","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.waojou.2018.12.001_bib26","doi-asserted-by":"crossref","first-page":"A688","DOI":"10.1016\/j.jval.2015.09.2550","article-title":"Quantifying the cost and quality of life implications of adverse events associated with long-term oral corticosteroid use","volume":"18","author":"Tilden","year":"2015","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.waojou.2018.12.001_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12931-017-0614-x","article-title":"The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis","volume":"18","author":"Barry","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.waojou.2018.12.001_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12948-017-0065-4","article-title":"SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma","volume":"15","author":"Senna","year":"2017","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.waojou.2018.12.001_bib29","series-title":"European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018, Munich","article-title":"Severe Asthma Network Italy (SANI): first results from a national severe asthma registry","author":"Ferrando","year":"2018"},{"issue":"10","key":"10.1016\/j.waojou.2018.12.001_bib31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.numecd.2016.05.002","article-title":"The relative burden of diabetes complications on healthcare costs: the population-based CINECA-SID ARNO Diabetes Observatory","volume":"26","author":"Pagano","year":"2016","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.waojou.2018.12.001_bib32","doi-asserted-by":"crossref","first-page":"e013899","DOI":"10.1136\/bmjopen-2016-013899","article-title":"Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis","volume":"7","author":"Colao","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.waojou.2018.12.001_bib33","article-title":"Il costo delle fratture da osteoporosi in Italia. Risultati dello studio BLO CK (Bone Loss and Osteoporosis: cost-of-illness Knowledge)","volume":"12","author":"Degli Esposti","year":"2011","journal-title":"Farmecon Percorsi Ter"},{"issue":"5","key":"10.1016\/j.waojou.2018.12.001_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000104765","volume":"221","author":"Koleva","year":"2007","journal-title":"Ophthalmologica"},{"issue":"7","key":"10.1016\/j.waojou.2018.12.001_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10198-016-0830-1","article-title":"The social cost of chronic kidney disease in Italy","volume":"18","author":"Turchetti","year":"2017","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.waojou.2018.12.001_bib36","unstructured":"Global Initiative for Asthma, https:\/\/ginasthma.org. (Accessed 19 July 2018)."},{"key":"10.1016\/j.waojou.2018.12.001_bib37","article-title":"The severe asthma Network in Italy (SANI): findings and perspectives","author":"Heffler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2018.12.001_bib38","first-page":"375","article-title":"Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy","volume":"4","author":"Ruggeri","year":"2012","journal-title":"Clinicoecon Outcomes Res"},{"issue":"10","key":"10.1016\/j.waojou.2018.12.001_bib39","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.clinthera.2011.09.009","article-title":"Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review","volume":"33","author":"Sarnes","year":"2011","journal-title":"Clin Therapeut"},{"issue":"6","key":"10.1016\/j.waojou.2018.12.001_bib40","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaci.2015.07.046","article-title":"Acute and chronic systemic corticosteroid-related complications in patients with severe asthma","volume":"136","author":"Lefebvre","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2018.12.001_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2147\/CEOR.S115025","article-title":"Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis","volume":"8","author":"Luskin","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.waojou.2018.12.001_bib42","article-title":"Strategies to reduce corticosteroid-related adverse events in asthma","author":"Heffler","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2018.12.001_bib43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2018.12.001_bib44","doi-asserted-by":"crossref","first-page":"e0183869","DOI":"10.1371\/journal.pone.0183869","article-title":"The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: the ASTERIX Observational study","volume":"12","author":"Bhutani","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.waojou.2018.12.001_bib45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.waojou.2018.12.001_bib46","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.waojou.2018.12.001_bib47","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.waojou.2018.12.001_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/ACI.0000000000000416","article-title":"Asthma: personalized and precision medicine","volume":"18","author":"Canonica","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2018.12.001_bib49","first-page":"45","article-title":"Cost-utility of add-on omalizumab in difficult-to-treat allergic asthma in Italy","volume":"43","author":"Dal Negro","year":"2011","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2018.12.001_bib50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1398-9995.2008.01723.x","article-title":"An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma","volume":"63","author":"Sullivan","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2018.12.001_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s40273-018-0658-x","article-title":"Cost-Effectiveness of biological asthma treatments: a systematic review and recommendations for future economic evaluations","author":"McQueen","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.waojou.2018.12.001_bib52","article-title":"Trends in omalizumab utilization for asthma: evidence of suboptimal patient selection","author":"Jeffery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119300523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119300523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:40:53Z","timestamp":1761849653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119300523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["S1939455119300523"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2018.12.001","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shadow cost of oral corticosteroids-related adverse events: A\u00a0pharmacoeconomic evaluation applied to real-life data from\u00a0the\u00a0Severe\u00a0Asthma Network in Italy (SANI) registry","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100007"}}